CAI Caris Life Sciences, Inc.

NASDAQ
$21.80

Caris Life Sciences, Inc. (CAI) is expected to report earnings on November 4, 2026, after the market close. The consensus earnings estimate is $0.03 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +14.7% since its last earnings release on August 5, 2026.

Caris Life Sciences Beat Consensus Estimates, Raises Guidance
Wednesday, August 5, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 4
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs $0.03
Rev est $262.78M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $22.01

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Caris Life Sciences, Inc.

Caris Life Sciences® (Caris) is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer that is actively developing and commercializing innovative solutions to transform healthcare.

Sector

Healthcare

Industry

Medical Labs & Research